BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18209071)

  • 1. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance.
    Tzelepis F; de Alencar BC; Penido ML; Claser C; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
    J Immunol; 2008 Feb; 180(3):1737-48. PubMed ID: 18209071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
    Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
    Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
    Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
    Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.
    Dominguez MR; Silveira EL; de Vasconcelos JR; de Alencar BC; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
    PLoS One; 2011; 6(7):e22011. PubMed ID: 21779365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS; Wipke BT; Van Voorhis WC
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients.
    Marañón C; Egui A; Carrilero B; Thomas MC; Pinazo MJ; Gascón J; Segovia M; López MC
    Microbes Infect; 2011 Nov; 13(12-13):1025-32. PubMed ID: 21704723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen.
    Millar AE; Kahn SJ
    Infect Immun; 2000 Jun; 68(6):3574-80. PubMed ID: 10816514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo.
    Huang J; Li X; Kohno K; Hatano M; Tokuhisa T; Murray PJ; Brocker T; Tsuji M
    J Immunol Methods; 2013 Jan; 387(1-2):254-61. PubMed ID: 23142461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.
    Freire-de-Lima L; Alisson-Silva F; Carvalho ST; Takiya CM; Rodrigues MM; DosReis GA; Mendonça-Previato L; Previato JO; Todeschini AR
    J Biol Chem; 2010 Apr; 285(18):13388-96. PubMed ID: 20106975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
    Wrightsman RA; Luhrs KA; Fouts D; Manning JE
    Parasite Immunol; 2002 Aug; 24(8):401-12. PubMed ID: 12406194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
    Martin DL; Weatherly DB; Laucella SA; Cabinian MA; Crim MT; Sullivan S; Heiges M; Craven SH; Rosenberg CS; Collins MH; Sette A; Postan M; Tarleton RL
    PLoS Pathog; 2006 Aug; 2(8):e77. PubMed ID: 16879036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.
    Ersching J; Vasconcelos JR; Ferreira CP; Caetano BC; Machado AV; Bruna-Romero O; Baron MA; Ferreira LR; Cunha-Neto E; Rock KL; Gazzinelli RT; Rodrigues MM
    PLoS Pathog; 2016 Apr; 12(4):e1005593. PubMed ID: 27128676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8.
    Rottenberg ME; Riarte A; Sporrong L; Altcheh J; Petray P; Ruiz AM; Wigzell H; Orn A
    Immunol Lett; 1995 Feb; 45(1-2):53-60. PubMed ID: 7622189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
    Vasconcelos JR; Bruña-Romero O; Araújo AF; Dominguez MR; Ersching J; de Alencar BC; Machado AV; Gazzinelli RT; Bortoluci KR; Amarante-Mendes GP; Lopes MF; Rodrigues MM
    PLoS Pathog; 2012; 8(5):e1002699. PubMed ID: 22615561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.
    Rosenberg CS; Martin DL; Tarleton RL
    J Immunol; 2010 Jul; 185(1):560-8. PubMed ID: 20530265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.